Paxlovid
Chinese Azvudone for COVID-19 China approves homegrown oral antiviral for treating COVID-19

The Chinese company producing Azvudone claimed that 40% of COVID-19 patients administered the drug for more than a week during the third phase of the clinical trial showed improvements when it came to symptoms

The people of the world vs Pfizer Inc.

During the Covid-19 pandemic, Pfizer has used every opportunity to maximize its profits, even if this meant reduced access to life-saving medical products for most of the world. The same is about to happen in the case of Paxlovid, the company’s Covid-19 oral treatment

Not Omicron but greed of capital threatens the world

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn